We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Anaerobic Chamber Ideal for Low Oxygen Conditions

By LabMedica International staff writers
Posted on 24 May 2012
An anaerobic chamber is ideal for low oxygen conditions in microaerophilic bacteriology, tissue, and cell culture applications.

The Shel Lab Bactrox chamber was introduced by Sheldon Manufacturing, Inc. More...
(Cornelius, OR, USA) and is the latest addition to its Bactron line of anaerobic chambers. The Bactrox offers precise oxygen and carbon dioxide control from 1%-20%.

The Bactrox is suitable for clinical and research microbiology, stem cell research, and mammalian cancer research. The chamber preserves optimal application conditions not only during incubation but also in the chamber workstation. Removal of cultures from the incubator does not require exposure of cells to undesirable oxygen or carbon dioxide levels.

The atmosphere in the unit is controlled by an accurate and long-lasting zirconium dioxide oxygen sensor, with independent oxygen and carbon dioxide control and logging. This minimizes setting up time. The Bactrox also has a standalone 300 plate incubator so users can comfortably work without gloves in ambient room conditions.

There is a large vacuum-less sample pass box that takes only 60 seconds to purge. The new design provides a vacuum-less sleeve entry into the chamber. Other features of this unit include temperature control and logging, superior condensation control, and ultra-bright light-emitting diode (LED) examination lights inside the chamber.

Related Links:

Sheldon Manufacturing




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Platelet Function Analyzer
PL-12
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The approach uses in-house pathology tests and streamlined access to specialists to shorten the diagnostic pathway for children with immune conditions. (Image Credit: iStock)

Streamlined Genetic Testing Speeds Pediatric Immune Disorder Diagnosis

Children with genetic immune conditions can develop life-threatening illness, unusual infections, or autoimmune problems before the underlying cause is identified. More than 500 of these rare disorders... Read more

Immunology

view channel
Image: Acute myeloid leukemia is the first of several disease areas the collaborators plan to pursue together as part of efforts to advance precision diagnostics (Image Credit: Adobe Stock)

Immune Profiling Initiative Aims to Improve Bone Marrow Analysis in Leukemia

Acute myeloid leukemia (AML) is an aggressive blood cancer in which assessing disease burden after therapy can help guide clinical evaluation. Patients with measurable residual disease (MRD) after treatment... Read more

Industry

view channel
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.